Selected research
Market Analysis & Forecast
Global Plasmid DNA Production & Manufacturing Service Market Analysis and Forecast 2026-2032
Market perspective
The global Plasmid DNA Production & Manufacturing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Plasmid DNA Production & Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Plasmid DNA Production & Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Plasmid DNA Production & Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Plasmid DNA Production & Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Plasmid DNA Production & Manufacturing Service include Charles River Laboratories, VGXI, Inc., Danaher (Aldevron), Kaneka Corp., Nature Technology, Cell and Gene Therapy Catapult, Eurofins Genomics, Lonza and Luminous BioSciences, LLC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Plasmid DNA Production & Manufacturing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Plasmid DNA Production & Manufacturing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Plasmid DNA Production & Manufacturing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasmid DNA Production & Manufacturing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasmid DNA Production & Manufacturing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasmid DNA Production & Manufacturing Service revenue, projected growth trends, production technology, application and end-user industry.
Plasmid DNA Production & Manufacturing Service Segment by Company
Charles River Laboratories
VGXI, Inc.
Danaher (Aldevron)
Kaneka Corp.
Nature Technology
Cell and Gene Therapy Catapult
Eurofins Genomics
Lonza
Luminous BioSciences, LLC
Akron Biotech
Plasmid DNA Production & Manufacturing Service Segment by Type
R&D Grade
GMP Grade
Plasmid DNA Production & Manufacturing Service Segment by Application
DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others
Plasmid DNA Production & Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA Production & Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA Production & Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA Production & Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Plasmid DNA Production & Manufacturing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Plasmid DNA Production & Manufacturing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasmid DNA Production & Manufacturing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D Grade
- GMP Grade
Applications
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
Companies covered
- Charles River Laboratories
- VGXI, Inc.
- Danaher (Aldevron)
- Kaneka Corp.
- Nature Technology
- Cell and Gene Therapy Catapult
- Eurofins Genomics
- Lonza
- Luminous BioSciences, LLC
- Akron Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Plasmid DNA Production & Manufacturing Service Market by Type
- 1.2.1 Global Plasmid DNA Production & Manufacturing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 R&D Grade
- 1.2.3 GMP Grade
- 1.3 Plasmid DNA Production & Manufacturing Service Market by Application
- 1.3.1 Global Plasmid DNA Production & Manufacturing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 DNA Vaccines
- 1.3.3 Cell & Gene Therapy
- 1.3.4 Immunotherapy
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plasmid DNA Production & Manufacturing Service Market Dynamics
- 2.1 Plasmid DNA Production & Manufacturing Service Industry Trends
- 2.2 Plasmid DNA Production & Manufacturing Service Industry Drivers
- 2.3 Plasmid DNA Production & Manufacturing Service Industry Opportunities and Challenges
- 2.4 Plasmid DNA Production & Manufacturing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Plasmid DNA Production & Manufacturing Service Market Perspective (2021-2032)
- 3.2 Global Plasmid DNA Production & Manufacturing Service Growth Trends by Region
- 3.2.1 Global Plasmid DNA Production & Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Plasmid DNA Production & Manufacturing Service Market Size by Region (2021-2026)
- 3.2.3 Global Plasmid DNA Production & Manufacturing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Plasmid DNA Production & Manufacturing Service Revenue by Players
- 4.1.1 Global Plasmid DNA Production & Manufacturing Service Revenue by Players (2021-2026)
- 4.1.2 Global Plasmid DNA Production & Manufacturing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Plasmid DNA Production & Manufacturing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Plasmid DNA Production & Manufacturing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Plasmid DNA Production & Manufacturing Service Key Players Headquarters & Area Served
- 4.4 Global Plasmid DNA Production & Manufacturing Service Players, Product Type & Application
- 4.5 Global Plasmid DNA Production & Manufacturing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Plasmid DNA Production & Manufacturing Service Market CR5 and HHI
- 4.6.3 2025 Plasmid DNA Production & Manufacturing Service Tier 1, Tier 2, and Tier 3
5 Plasmid DNA Production & Manufacturing Service Market Size by Type
- 5.1 Global Plasmid DNA Production & Manufacturing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2032)
- 5.3 Global Plasmid DNA Production & Manufacturing Service Revenue Market Share by Type (2021-2032)
6 Plasmid DNA Production & Manufacturing Service Market Size by Application
- 6.1 Global Plasmid DNA Production & Manufacturing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2032)
- 6.3 Global Plasmid DNA Production & Manufacturing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Charles River Laboratories
- 7.1.1 Charles River Laboratories Company Information
- 7.1.2 Charles River Laboratories Business Overview
- 7.1.3 Charles River Laboratories Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Charles River Laboratories Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.1.5 Charles River Laboratories Recent Developments
- 7.2 VGXI, Inc.
- 7.2.1 VGXI, Inc. Company Information
- 7.2.2 VGXI, Inc. Business Overview
- 7.2.3 VGXI, Inc. Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 VGXI, Inc. Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.2.5 VGXI, Inc. Recent Developments
- 7.3 Danaher (Aldevron)
- 7.3.1 Danaher (Aldevron) Company Information
- 7.3.2 Danaher (Aldevron) Business Overview
- 7.3.3 Danaher (Aldevron) Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Danaher (Aldevron) Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.3.5 Danaher (Aldevron) Recent Developments
- 7.4 Kaneka Corp.
- 7.4.1 Kaneka Corp. Company Information
- 7.4.2 Kaneka Corp. Business Overview
- 7.4.3 Kaneka Corp. Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Kaneka Corp. Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.4.5 Kaneka Corp. Recent Developments
- 7.5 Nature Technology
- 7.5.1 Nature Technology Company Information
- 7.5.2 Nature Technology Business Overview
- 7.5.3 Nature Technology Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Nature Technology Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.5.5 Nature Technology Recent Developments
- 7.6 Cell and Gene Therapy Catapult
- 7.6.1 Cell and Gene Therapy Catapult Company Information
- 7.6.2 Cell and Gene Therapy Catapult Business Overview
- 7.6.3 Cell and Gene Therapy Catapult Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Cell and Gene Therapy Catapult Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.6.5 Cell and Gene Therapy Catapult Recent Developments
- 7.7 Eurofins Genomics
- 7.7.1 Eurofins Genomics Company Information
- 7.7.2 Eurofins Genomics Business Overview
- 7.7.3 Eurofins Genomics Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Eurofins Genomics Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.7.5 Eurofins Genomics Recent Developments
- 7.8 Lonza
- 7.8.1 Lonza Company Information
- 7.8.2 Lonza Business Overview
- 7.8.3 Lonza Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Lonza Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.8.5 Lonza Recent Developments
- 7.9 Luminous BioSciences, LLC
- 7.9.1 Luminous BioSciences, LLC Company Information
- 7.9.2 Luminous BioSciences, LLC Business Overview
- 7.9.3 Luminous BioSciences, LLC Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Luminous BioSciences, LLC Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.9.5 Luminous BioSciences, LLC Recent Developments
- 7.10 Akron Biotech
- 7.10.1 Akron Biotech Company Information
- 7.10.2 Akron Biotech Business Overview
- 7.10.3 Akron Biotech Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Akron Biotech Plasmid DNA Production & Manufacturing Service Product Portfolio
- 7.10.5 Akron Biotech Recent Developments
8 North America
- 8.1 North America Plasmid DNA Production & Manufacturing Service Revenue (2021-2032)
- 8.2 North America Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2032)
- 8.2.1 North America Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2026)
- 8.2.2 North America Plasmid DNA Production & Manufacturing Service Revenue by Type (2027-2032)
- 8.3 North America Plasmid DNA Production & Manufacturing Service Revenue Share by Type (2021-2032)
- 8.4 North America Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2032)
- 8.4.1 North America Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2026)
- 8.4.2 North America Plasmid DNA Production & Manufacturing Service Revenue by Application (2027-2032)
- 8.5 North America Plasmid DNA Production & Manufacturing Service Revenue Share by Application (2021-2032)
- 8.6 North America Plasmid DNA Production & Manufacturing Service Revenue by Country
- 8.6.1 North America Plasmid DNA Production & Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Plasmid DNA Production & Manufacturing Service Revenue by Country (2021-2026)
- 8.6.3 North America Plasmid DNA Production & Manufacturing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Plasmid DNA Production & Manufacturing Service Revenue (2021-2032)
- 9.2 Europe Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2032)
- 9.2.1 Europe Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2026)
- 9.2.2 Europe Plasmid DNA Production & Manufacturing Service Revenue by Type (2027-2032)
- 9.3 Europe Plasmid DNA Production & Manufacturing Service Revenue Share by Type (2021-2032)
- 9.4 Europe Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2032)
- 9.4.1 Europe Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2026)
- 9.4.2 Europe Plasmid DNA Production & Manufacturing Service Revenue by Application (2027-2032)
- 9.5 Europe Plasmid DNA Production & Manufacturing Service Revenue Share by Application (2021-2032)
- 9.6 Europe Plasmid DNA Production & Manufacturing Service Revenue by Country
- 9.6.1 Europe Plasmid DNA Production & Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Plasmid DNA Production & Manufacturing Service Revenue by Country (2021-2026)
- 9.6.3 Europe Plasmid DNA Production & Manufacturing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Plasmid DNA Production & Manufacturing Service Revenue (2021-2032)
- 10.2 China Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2032)
- 10.2.1 China Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2026)
- 10.2.2 China Plasmid DNA Production & Manufacturing Service Revenue by Type (2027-2032)
- 10.3 China Plasmid DNA Production & Manufacturing Service Revenue Share by Type (2021-2032)
- 10.4 China Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2032)
- 10.4.1 China Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2026)
- 10.4.2 China Plasmid DNA Production & Manufacturing Service Revenue by Application (2027-2032)
- 10.5 China Plasmid DNA Production & Manufacturing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Plasmid DNA Production & Manufacturing Service Revenue (2021-2032)
- 11.2 Asia Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2032)
- 11.2.1 Asia Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2026)
- 11.2.2 Asia Plasmid DNA Production & Manufacturing Service Revenue by Type (2027-2032)
- 11.3 Asia Plasmid DNA Production & Manufacturing Service Revenue Share by Type (2021-2032)
- 11.4 Asia Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2032)
- 11.4.1 Asia Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2026)
- 11.4.2 Asia Plasmid DNA Production & Manufacturing Service Revenue by Application (2027-2032)
- 11.5 Asia Plasmid DNA Production & Manufacturing Service Revenue Share by Application (2021-2032)
- 11.6 Asia Plasmid DNA Production & Manufacturing Service Revenue by Country
- 11.6.1 Asia Plasmid DNA Production & Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Plasmid DNA Production & Manufacturing Service Revenue by Country (2021-2026)
- 11.6.3 Asia Plasmid DNA Production & Manufacturing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Plasmid DNA Production & Manufacturing Service Revenue (2021-2032)
- 12.2 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Type (2027-2032)
- 12.3 SAMEA Plasmid DNA Production & Manufacturing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Application (2027-2032)
- 12.5 SAMEA Plasmid DNA Production & Manufacturing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Country
- 12.6.1 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Plasmid DNA Production & Manufacturing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst